Vim li cas Mask Neuropathic Mob Thaum Koj tuaj yeem thaiv Polyol Txoj Kev? Epalrestat API (CAS 82159-09-9)

Aug 11, 2026

Tso lus

Vim li cas Mask Neuropathic Mob Thaum Koj tuaj yeem thaiv Polyol Txoj Kev? Epalrestat API (CAS 82159-09-9)

 

Ib daim ntawv R&D Whitepaper ntawm Aldose Reductase Inhibition, Sorbitol Accumulation, thiab Siab -Fidelity Isomeric Synthesis hauv Kev Kho Mob Ntshav Qab Zib.

Formulation Insight & Ntiaj Teb Kev Noj Qab Haus Huv cuam tshuam:Mob ntshav qab zib peripheral neuropathy yog ib qho teeb meem loj heev hauv microvascular uas cuam tshuam ntau dua 50% ntawm cov neeg mob ntshav qab zib hauv ntiaj teb. Tus tib neeg tus nqi yog staggering: tsis kub hnyiab tau hnov, excruciating paresthesia, ua tiav tactile rhiab heev, thiab thaum kawg, ib tug siab yuav txo tau ntawm qis dua -limb amputation. Txawm hais tias qhov mob hnyav ntawm tus mob no, lub khw muag tshuaj sab hnub poob yog tam sim no saturated nrog palliative kev cuam tshuam. Cov tshuaj xws li gabapentin, pregabalin, thiab duloxetine tau sau tseg hauv cov ntim loj. Txawm li cas los xij, cov neeg ua haujlwm no tsuas yog ua rau lub hauv paus paj hlwb txoj kev nkag siab ntawm qhov mob; lawv tsis ua dab tsi los nres lossis thim rov qab kev puas tsuaj tas mus li ntawm cov hlab ntsha peripheral.

Txhawm rau khaws cov paj hlwb, cov qauv tsim yuav tsum tawm tsam qhov tseeb biochemical pathogenesis ntawm tus kab mob.Epalrestat (CAS 82159-09-9)tsis yog tshuaj kho mob. Nws yog ib qho muaj zog heev, tsom rau Aldose Reductase Inhibitor (ARI). Los ntawm ncaj qha thaiv qhov tsis txaus ntseeg metabolic cascade hu ua txoj hauv kev polyol, Epalrestat tso tseg cov tshuaj lom ntawm cov sorbitol hauv intracellular, tiv thaiv Schwann hlwb thiab kho cov hlab ntsha kev tshaj tawm. Cov lus piav qhia ntxaws ntxaws no nthuav tawm cov txheej txheem biochemical ntawm aldose reductase inhibition, nthuav tawm qhov tsis muaj txiaj ntsig ntawm kev tswj xyuas qhov mob, thiab qhia meej meej, isomerically tswj cov tshuaj synthesis raws tu qauv ua tiav ntawm Xi'an Tihealth.

Why Mask Neuropathic Pain When You Can Block the Polyol Pathway 1

1. Molecular Architecture: Dismantling Polyol Txoj Kev

Txhawm rau ua kom muaj txiaj ntsig zoo ntawm Epalrestat hauv cov kav dej metabolic, cov thawj coj yuav tsum nkag siab tob txog qhov kev puas tsuaj cytological tshwm sim los ntawm kev mob hyperglycemia. Nyob rau hauv ib txwm physiological tej yam kev mob, intracellular qabzib yog metabolized ntawm hexokinase rau lub zog. Txawm li cas los xij, thaum mob ntshav qab zib mellitus, cov piam thaj hauv ib puag ncig tau nce siab, dhau ntawm txoj kev hexokinase. Cov piam thaj ntau dhau yog shunted rau hauv kev puas tsuaj metabolic: Txoj Kev Polyol. Epalrestat (C15H13TSIS MUAJ3S2) yog carboxylic acid derivative tshwj xeeb tsim los kaw qhov kev taug kev no.

01

Inhibiting Aldose Reductase: Tus Nqi -Txoj Kev Txwv

Thawj thiab tus nqi - txwv cov kauj ruam ntawm txoj kev polyol yog catalyzed los ntawm enzymealdose reductase, uas hloov cov piam thaj ntau dhau rau hauv sorbitol. Vim hais tias cov cell membranes yog cov impermeable heev rau sorbitol, cov kua qab zib no sai sai accumulates nyob rau hauv peripheral paj hlwb, Schwann hlwb, thiab cov ntaub so ntswg retinal. Epalrestat yog lub zog, tsis yog - sib tw, thiab thim rov qab inhibitor ntawm aldose reductase. Los ntawm kev xaiv khi rau cov enzyme, Epalrestat thaiv cov txheej txheem hloov pauv tag nrho, poob qis hauv cov cellular sorbitol qib rov qab mus rau kev nyab xeeb, lub hauv paus ntawm lub cev.

02

Reversing Osmotic Stress thiab Demyelination

Kev sib sau ntawm sorbitol tsis yog tsuas yog metabolic anomaly; nws tsim kom tuag osmotic gradient. Dej nyab mus rau hauv cov paj hlwb kom sib npaug ntawm qhov siab sorbitol concentration, ua rau mob hnyav cellular o, kev puas tsuaj rau myelin sheath, thiab lub cev qhuav dej ntawm Node ntawm Ranvier. Qhov no lub cev o ncaj qha impairs lub cev muaj zog thiab sensory paj conduction tshaj tawm. Los ntawm kev tshem tawm lub nra ntawm sorbitol, Epalrestat tam sim ntawd txo qhov kev ntxhov siab osmotic, tso cai rau cov txheej txheem ntawm cov hlab ntsha kom ruaj khov thiab rov tsim dua tshiab.

03

Rescuing Na+/K+-ATPase thiab Glutathione Levels

Txoj kev khiav tawm ntawm cov polyol viciously noj NADPH, ib qho tseem ceeb ntawm cellular cofactor yuav tsum tau regenerate glutathione- lub cev thawj intracellular antioxidant. Yog li ntawd, cov ntshav qab zib cov hlab ntsha raug kev txom nyem los ntawm oxidative kev nyuaj siab. Tsis tas li ntawd, sorbitol txuam nrog depletes myo-inositol, uas ua rau txo qis cov Na.+/K+-ATPase twj tso kua mis lub luag hauj lwm rau firing paj hlwb tej yam kev mob. Los ntawm kev kaw aldose reductase, Epalrestat khaws cia NADPH pas dej ua ke, tshem tawm cov kev ntxhov siab oxidative, thiab rov ua haujlwm ntawm lub twj tso kua mis ionic uas xav tau rau kev hnov ​​​​lus zoo.

Why Mask Neuropathic Pain When You Can Block the Polyol Pathway 2

2. Forensic Formulation Matrix: Epalrestat vs. Symptomatic Treatments

Rau cov pab pawg kws kho mob, muab Epalrestat nyob rau hauv kev ua lag luam yuav tsum tau hais txog nws cov kab mob tseem ceeb - hloov peev xwm piv rau cov tshuaj hauv nruab nrab paj hlwb.

Pharmacological Parameter Cov tsos mob (piv txwv li, Gabapentin, Pregabalin) Xi'an Tihealth Epalrestat API (CAS 82159-09-9)
Mechanism ntawm Action Modulates calcium channels hauv CNS los thaiv cov cim mob. Inhibits aldose reductase hauv cov hlab ntsha peripheral; tiv thaiv cov ntaub so ntswg puas.
Kev cuam tshuam rau Nerve Pathology Zero. Cov hlab ntsha tseem degenerate thaum qhov mob yog npog. Kab mob -Kev hloov kho. Restores hlab ntsha conduction tshaj tawm lub sij hawm.
Cov teebmeem tshwm sim Mob hnyav kiv taub hau, somnolence, kev paub tsis meej, thiab kev pheej hmoo ntawm kev vam meej. Highly localized enzyme targeting; CNS cov kev mob tshwm sim tsis zoo.
Cov txiaj ntsig ntawm Kev Kho Mob Tseem Ceeb Kev kho mob ib ntus rau qib siab -theem neuropathy. Kev tiv thaiv kev kis kab mob; ua tau zoo heev hauv - kev cuam tshuam thaum ntxov.

3. Lub Xi'an Tihealth Advantage: Siab -Fidelity Isomeric Synthesis

Epalrestat yog structurally complex. Nws nta cov saw hlau carboxylic acid txuas nrog lub nplhaib rhodanine, cuam tshuam nrog ob daim ntawv cog lus tseem ceeb uas nthuav tawm cov teeb meem stereochemical hnyav. Kev tsim khoom tsis zoo feem ntau tsis tswj hwm Z / E isomerization thaum lub sijhawm Knoevenagel condensation. Qhov kev ua tsis tiav no ua rau API dej nyab nrog cov neeg tsis muaj zog stereoisomers, txo qis kev kho mob ua tau zoo thiab ua rau cov txheej txheem tswj xyuas cov ntaub ntawv nyuaj.

NtawmXi'an Tihealth Biotechnology Co., Ltd., peb kho cov synthesis ntawm no cim reddish - txiv kab ntxwv crystalline hmoov nrog uncompromising precision. Peb cov txheej txheem kev tsim kho chemical tau lees paub qhov tseeb stereochemical fidelity thiab xoom residual toxicity:

Stereochemical Precision

nruj Z/E Isomer Control

Txoj kev kho mob zoo ntawm Epalrestat yog nyob ntawm kev tswj hwm nws cov geometric configuration meej. Peb siv optimized organocatalysts thiab nruj ntsuas ntsuas kub thaum lub sij hawm rhodanine condensation cov tshuaj tiv thaiv. Qhov no ua kom ntseeg tau tias qhov kawg geometric kev npaj hnyav hnyav rau kev lom neeg isomer, ua tiav qhov kev tsis sib haum xeeb isomeric purity uas dhau qhov kev soj ntsuam nruj spectroscopic.

Ntsuab Chemistry

Solvent Recovery & USP<467>Ua raws li

Complex carboxylic acid synthesis xav tau cov kuab tshuaj organic, tab sis qhov kawg API yuav tsum yog pristine. Xi'an Tihealth ntiav cov tswv kaw -loop solvent recovery systems. Ua raws li cov txheej txheem recrystallization siab heev, API tau raug mob siab heev -nqus purging. Peb lav tias cov kuab tshuaj residual poob qis qis dua hauv Chav Kawm 2 thiab Chav Kawm 3 qhov pib raug txib los ntawm cov chaw muag tshuaj thoob ntiaj teb.

Kev Tshawb Fawb Txog Kev Tshawb Fawb

HPLC & Poob ntawm Kev Tshawb Fawb Qhuav

Peb tsis cia siab rau theoretical chemistry. Txhua qhov kev lag luam batch yog forensically audited ntawm High-Performance Liquid Chromatography (HPLC) kom paub meej tias tsis muaj kiag li muaj feem xyuam rau cov hluavtaws impurities, yielding ibNtau dua lossis sib npaug rau 99.0% kev xeem. Tsis tas li ntawd, meej Karl-Fisher titration ua kom cov dej noo tswj tau zoo rau cov ntsiav tshuaj hauv qab thiab ntim khoom.

4. Muaj Daim Ntawv Thov Kev Ua Haujlwm rau Epalrestat API

Vim tias Epalrestat muaj kev ruaj khov heev hauv cov ntaub ntawv hauv xeev -, nws yooj yim hla qhov nyuaj ntawm cov kua roj ntsha lom neeg, muab CDMOs thiab cov tswv lag luam ib txoj hauv kev mus rau kev lag luam:

Ib zaug -Cov Ntsiab Lus Txhua Hnub

Kev kho mob thawj zaug. Peb cov crystalline API nthuav tawm cov khoom ntim zoo heev thiab muaj peev xwm txaus, tso cai rau sai, siab - cov khoom lag luam tawm los ntawm cov txheej txheem compression ncaj qha lossis ntub dej granulation. Feem ntau tsim nyob rau hauv 50mg koob tshuaj noj ua ntej noj mov.

Clinical Research & Ophthalmic Exploration

Tshaj li peripheral neuropathy, Aldose Reductase plays lub luag haujlwm tseem ceeb hauv ntshav qab zib retinopathy thiab cataracts. Peb lub siab -purity API muab cov chaw tshawb fawb nrog lub hauv paus txhim khu kev qha, tsis muaj kab mob los tsim cov tshuaj tua kab mob siab tshaj plaws thiab cov phiaj xwm xa tawm tshiab.

Formulator & Procurement FAQ

Q1: Vim li cas Epalrestat tshwm sim ua liab liab - txiv kab ntxwv hmoov tsis yog cov qauv dawb?

Tsis zoo li ntau APIs, cov xim liab txawv txawv -txiv kab ntxwv lossis daj- xim liab ntawm Epalrestat tsis yog qhov tsis huv; nws yog lub cev muaj zog ntawm nws cov khoom siv tshwj xeeb polyene thiab rhodanine nplhaib qauv absorbing tshwj xeeb wavelengths ntawm lub teeb. Ntawm Xi'an Tihealth, peb tau lees tias qhov xim profile no phim cov qauv spectrophotometric tiag tiag uas yuav tsum tau muaj rau ib qho ultra- ntshiab, zoo synthesized molecule.

Q2: Puas yog API rhiab rau lub teeb thaum khaws cia thiab tsim khoom?

Yog lawm, vim nws txoj kev sib koom ua ke ob daim ntawv cog lus, Epalrestat tuaj yeem raug yees duab- ntxias isomerization yog tias raug ultraviolet muaj zog lossis tshav ntuj ncaj qha rau lub sijhawm ntev. Peb nruj me ntsis ntim tag nrho cov khoom xa tuaj rau hauv 25KG fiber ntau nruas siv qhov tsaus, lub teeb -tiv taus ob- txheej tshuaj PE hnab. Formulators raug qhia kom siv cov iav amber iav thiab tsis txhob raug lub teeb ncaj qha thaum lub sij hawm tshuaj ntsiav thiab txheej txheej.

Q3: Koj puas muab cov ntaub ntawv txheeb xyuas dav dav rau kev ua raws cai?

kiag li. Xi'an Tihealth ua haujlwm tag nrho nyob rau hauv ISO9001: 2015 thiab GMP- ua raws cov txheej txheem rau peb cov khoom siv tshuaj. Txhua pawg xa tawm ntawm Epalrestat API yog nrog los ntawm cov ntaub ntawv ua tiav, suav nrog Daim Ntawv Pov Thawj Kev Ntsuam Xyuas (COA), siab - daws teeb meem HPLC chromatograms lees paub stereochemical purity, thiab nruj GC cov kuab tshuaj residue cov ntaub ntawv los pab txhawb koj qhov QA kev soj ntsuam thiab DMF substream.

Target lub hauv paus ua rau mob ntshav qab zib neuropathy nrog cov kab mob - hloov kho, siab -purity API.

Thov HPLC Chromatogram & Bulk Pricing

Sau los ntawm Wang Xueyan, Technical Operations & Formulation Strategy ntawm Xi'an Tihealth Biotechnology Co., Ltd.

* Kev lees paub tsis raug cai: Muab tshwj xeeb raws li qhov tsis muaj npe, tshawb fawb -qib Cov Khoom Siv Tshuaj (API). Cov koom haum yuav khoom tsuas yog lub luag haujlwm rau kev tsim kho zaum kawg, kev sim tshuaj ntsuam xyuas, kev nyab xeeb sib xyaw, thiab kev tswj hwm nruj hauv lawv txoj cai thoob ntiaj teb.*

 

Xa kev nug